Table 3.
SARS‐CoV‐2‐positive inpatient cohort (N = 4) | SARS‐CoV‐2‐positive community cohort (N = 4) | |
---|---|---|
Age (years) | ||
Range (average) | 44–67 (55.5) | 37–79 (56.3) |
<65 | 3 | 4 |
≥65 | 1 | 1 |
Male/female ratio | 3:1 | 2:2 |
Black/white ratio | 4:0 | 3:1 |
BMI range (average) | 21.7–48.5 (34.7) | 18.5–46.6 (31.9) |
Presenting/premortem symptoms | ||
Fever | 4 (100) | 1 (25) |
Cough | 4 (100) | 1 (25) |
Myalgia | 3 (75) | 1 (25) |
Dyspnoea | 2 (50) | 2 (50) |
Headache | 2 (50) | 0 (0) |
GI complaints | 1 (25) | 1 (25) |
None/unknown | 0 (0) | 2 (25) |
Medical conditions | ||
Diabetes | 4 (100) | 1 (25) |
Chronic lung disease | 2 (50) | 0 (0) |
Cardiovascular disease | 1 (25) | 2 (25) |
Immunocompromised condition | 1 (25) | 0 (0) |
Chronic renal disease | 0 (0) | 1 (25) |
BMI, body mass index; GI, gastrointestinal.